K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines
Yvonne Yeung, David K Lau, Fiona Chionh, Hoanh Tran, Janson WT Tse, Andrew J Weickhardt, Mehrdad Nikfarjam, Andrew M Scott, Niall C Tebbutt, John M Mariadason
Molecular Oncology | WILEY | Published : 2017
Awarded by Victorian Cancer Agency
Awarded by NHMRC
This project was supported by the Victorian Cancer Agency (TRP13083), a NHMRC Senior Research Fellowship (1046092) to JMM, a NHMRC Senior Practitioner Fellowship (1084178) to AMS, a NHMRC Postgraduate Research Scholarship (1017737) to FC, Ludwig Cancer Research and the Operational Infrastructure Support Program, Victorian Government, Australia. YY was supported by a Fellowship from the ANZ Trustees Foundation - Brian Smith Endowment. DL and JT were supported by Australian Postgraduate Awards and DL by a scholarship from the Pancare Foundation.